Sepe, Dana M <br/><br/>
Dexrazoxane as a cardioprotectant in children receiving anthracyclines.  [electronic resource] 

 -  The oncologist  2010 
 - 1220-6 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1549-490X 
<br/><br/><label>Standard No.: </label>10.1634/theoncologist.2010-0162  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Anthracyclines--administration & dosage<br/>Antineoplastic Agents--adverse effects<br/>Arrhythmias, Cardiac--chemically induced<br/>Cardiomyopathies--chemically induced<br/>Cardiotonic Agents--administration & dosage<br/>Child<br/>Child, Preschool<br/>Heart Failure--chemically induced<br/>Humans<br/>Razoxane--administration & dosage<br/>Risk Factors<br/>Treatment Outcome<br/>Young Adult